CWSRF:OTC-Chartwell Retirement Residences (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 11.4

Change

0.00 (0.00)%

Market Cap

USD 3.10B

Volume

3.22K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Chartwell is in the business of serving and caring for Canada's seniors, committed to its vision of Making People's Lives BETTER and to providing a happier, healthier, and more fulfilling life experience for its residents. Chartwell is an unincorporated, open-ended real estate trust which indirectly owns and operates a complete range of seniors housing communities, from independent living through to assisted living and long term care. Chartwell is the largest operator in Canada, serving over 25,000 residents in four provinces across the country.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
ARSSF Assura Plc

N/A

USD 1.70B
PHPRF Primary Health Properties PLC

N/A

USD 1.59B
SILA Sila Realty Trust, Inc.

+0.24 (+0.95%)

USD 1.38B
HLTC HealthCare Inc

N/A

USD 0.34B
NWHUF Northwest Healthcare Propertie..

-0.04 (-0.86%)

N/A
PRKWF Parkway Life Real Estate Inves..

N/A

N/A

ETFs Containing CWSRF

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 32.87% 100% F 79% B-
Dividend Return 5.03% 60% D- 68% D+
Total Return 37.90% 100% F 80% B-
Trailing 12 Months  
Capital Gain 49.80% 100% F 83% B
Dividend Return 7.68% 60% D- 78% C+
Total Return 57.49% 100% F 84% B
Trailing 5 Years  
Capital Gain 3.89% 67% D+ 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.89% 67% D+ 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.81% N/A N/A 61% D-
Dividend Return 11.42% N/A N/A 65% D
Total Return 4.61% N/A N/A 77% C+
Risk Return Profile  
Volatility (Standard Deviation) 32.27% N/A N/A 31% F
Risk Adjusted Return 35.39% N/A N/A 52% F
Market Capitalization 3.10B 100% F 82% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector